Skip to content

Relationship between peripheral blood and tissue flora and gynecological diseases

Relationship between peripheral blood and tissue flora and gynecological diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800020018
Enrollment
Unknown
Registered
2018-12-11
Start date
2019-01-01
Completion date
Unknown
Last updated
2018-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecological diseases

Interventions

Ovarian cancer group, ovarian control group
endometrial cancer group, endometrial cancer control group
cervical cancer group, cervical cancer control group
hypertension in pregnancy group, hypertension in pregnancy control group
polycystic ovary syndrome Group, polycystic ovary syndrome control group:No

Sponsors

First Affiliated Hospital of Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Ovarian cancer group: All types of ovarian cancer patients with clear diagnosis (histopathological diagnosis must be performed). Ovarian cancer control group: patients with uterine fibroids and adenomyosis who are undergoing hysterectomy and salpingo-oopherectomy; Endometrial cancer group: Patients with diagnosed endometrial cancer. Endometrial cancer control group: patients with uterine fibroids or adenomyosis who are undergoing hysterectomy; Cervical cancer group: Patients with diagnosis of cervical cancer. Cervical cancer control group: a non-cervical cancer control patients with cervical brushing tissue; Hypertension in pregnancy group: Diagnosed hypertensive patient with pregnancy. Hypertensive control group during pregnancy: diagnosed scar uterus or patients undergoing cesarean section; Polycystic ovary syndrome group: Patients with diagnosed polycystic ovary syndrome (first diagnosis or no history of sex hormone use within one year). Polycystic ovary syndrome control group: physical examination of healthy women.

Exclusion criteria

Exclusion criteria: Patients with various acute and chronic inflammatory diseases (including urethritis, pneumonia, vaginitis, gingivitis, sputum and other skin infections, upper respiratory tract infections, etc.); Pantibiotics for nearly two months

Design outcomes

Primary

MeasureTime frame
flora;

Countries

China

Contacts

Public ContactQiling Li

First Affiliated Hospital of Xi'an Jiaotong University

liqilinglady@163.com+86 13991232838

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026